Digipath
Home > Boards > US Listed > Biotechs >

Yield 10 Bioscience (YTEN)

YTEN RSS Feed
Add YTEN Price Alert      Hide Sticky   Hide Intro
Moderator: FairviewInvestor
Search This Board: 
Last Post: 1/15/2019 12:46:44 PM - Followers: 32 - Board type: Free - Posts Today: 0

       
       

Yield10 Bioscience is an agricultural bioscience company focusing on the development of disruptive technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. Experts forecast that food production must be increased by over 70% in the next 35 years to feed the growing global population, which is expected to increase from 7 billion to more than 9.6 billion by 2050. Yield10 is focused on new agricultural biotechnology approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is working to develop, validate and commercialize new traits and identify gene editing targets in several key crops including canola, soybean and corn. Yield10 was launched by Metabolix, Inc. in 2015 and is traded on Nasdaq (YTEN). Yield10 is headquartered in Woburn, MA and has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.

History

Metabolix was founded in 1992 and focused on engineering microbes to make proprietary bioplastics and bio-based chemicals. In 2002, Metabolix started a crop science research program with the intent to harness the renewable nature of plants to produce renewable bioplastics, chemicals and bioenergy from agricultural crops. Historically, Metabolix put most of its crop technology efforts on developing proprietary systems to produce PHB, the simplest member of the PHA family of biopolymers, in high concentration in the seeds of oilseed crops or in the leaves of biomass crops for these applications.

With development advancing in our agricultural biotechnology approach and with our progress producing PHB in plants, we learned that producing PHB in increasing levels in the biomass of switchgrass resulted in impaired plant growth. This result is not unexpected, as we were diverting a significant fraction of the carbon fixed by the plants into PHB, which represented a new carbon sink. Given these observations and our longer-term goal at the time to develop commercially viable ways to produce PHB biopolymer in switchgrass and the industrial oilseed camelina, we began developing new genetic and informatics tools and began capturing intellectual propertyaround strategies to enhance the photosynthetic capacity of plants.

In 2015, we set a new mission and redeployed our crop science program, launching with the name “Yield10 Bioscience.” It is now developing proprietary, breakthrough plant biotechnologies to improve crop productivity and seed yield based on our “Smart Carbon Grid for Crops” and our metabolic engineering platform called the “T3” Platform. We are now focusing on advanced crop technologies to boost the CO2 fixation efficiency through photosynthesis as well as its direction to and conversion into plant matter. Our team has demonstrated yield improvements inswitchgrass biomass and camelina oilseed, and we are developing innovative agricultural biotechnology approaches in significant row crops to provide novel solutions for global food security.

                                              

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                                                                    2016 Update

Metabolix, Inc. is implementing a strategic plan under which the Company has wound down its legacy PHA biopolymer business and Yield10 Bioscience will become its core business with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is leveraging Metabolixs extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing several yield traits in development in crops such as camelina, canola, soybean and corn. The Company is based in Woburn, MA

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

Yield10 Bioscience is a planned spinout that will commercialize crop science innovations that Metabolix and its partners have developed over the last 10+ years. “Yield10” will focus on step changes in crop yield to enhance global food security. This will be achieved through enhanced carbon capture (photosynthesis) and targeted carbon deposition through advanced transcriptome targeted metabolic engineering. Target crops will include key row crops (corn, soybean, canola, sugarcane, sorghum, alfalfa) as well as industrial and energy crops (e.g. Camelina and switchgrass). The increased fixed carbon will be directed to products of interest through Yield10’s advanced metabolic engineering capabilities.

  • Oilseed crops – increase carbon flow to seed and oil
    Corn – increase carbon flow to seed and starch biosynthesis
    Biomass crops – increase carbon flow to sucrose (cane) or biomass
    Industrial and energy crops (e.g. Camelina, switchgrass, sugarcane) – increase carbon flow to industrial products (e.g. bioplastics)

Yield10 Bioscience: The Innovation Opportunity

A complex trait such as increased crop yield depends on many metabolic pathways enabling multiple processes, starting with photosynthetic carbon fixation and finishing with carbon conversion to end product. Because these processes involve multiple genes and pathways, traditional plant breeding or single transgene approaches are limited and provide only incremental gains in yield. Yield10 Bioscience will focus on identifying key combinations of genes to deliver step changes in crop yield. This will be achieved using the foundation “T3 Platform” technology developed at Metabolix that utilizes advanced transcriptome network analysis to identify key global regulatory genes, and the broad set of metabolic genes they control, with the potential to massively up-regulate key pathways. We have demonstrated the T3 Platform technology in switchgrass in gene discovery efforts focused on increasing photosynthesis and primary plant metabolism and have identified key global transcription factors that increase photosynthesis, biomass yield, and starch accumulation. This T3 Platform technology can be used to query gene data sets to discover methods to increase carbon flow to other metabolic pathways by changing the input information. In collaborations with leading academic groups, Metabolix has accessed additional novel traits each also targeting step changes in crop yield through metabolic engineering. The combination of in-house and licensed technologies combined with metabolic modeling, systems biology, and bioinformatics fully integrated through the T3 platform forms the technical foundation for the next generation of crop metabolic engineering to achieve step changes in yield. 

The company was founded in 1992, is based in Cambridge Massachusetts

 

Yield10 Reports 2016 Camelina Field Test Results for C3003 Yield Trait Gene 

Yield10 announced preliminary field test results in its model Camelina system showing that the novel yield trait gene C3003 produces significant improvements in seed yield. Specifically, C3003 produced an increase in seed yield in Camelina of up to 23% in the best line as measured by average seed weight (kg/hectare), which was statistically significant as compared to control plants. The field trials, which were started in May 2016, were primarily designed to establish Yield10’s Fast Field Testing platform and accelerate the generation of field data for crop trait discovery and improvement in addition to evaluating changes in seed yield and composition generated by specific trait leads in Camelina.

Read more about the Camelina results here.



 
Digipath
YTEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#506   The market does not appreciate these weak results... BMGS 01/15/19 12:46:44 PM
#505   This company is a joke. Management is not BMGS 01/15/19 09:19:51 AM
#504   Has room to $2.25 for a start. FairviewInvestor 01/07/19 10:21:35 AM
#503   DATA should be this week. Decent Data supports FairviewInvestor 01/05/19 01:51:12 PM
#502   Here’s hoping nsomniyak 12/31/18 04:43:03 PM
#501   My PT nothing short of $4+ on good FairviewInvestor 12/31/18 04:03:20 PM
#500   Lets hope we hear about a date soon...even bUrRpPPP! 12/26/18 05:32:13 PM
#499   I've spoken to Lynne Brumm and know her FairviewInvestor 12/19/18 06:22:56 PM
#498   High Risk / Reward.. if too much.. dump FairviewInvestor 12/19/18 06:20:59 PM
#497   Renaissance Technologies LLC increased its position in shares FairviewInvestor 12/19/18 06:19:52 PM
#496   Get real. Hardly cause to demand a resignation. nsomniyak 12/18/18 03:42:26 PM
#495   The CEO should obviously resign. Seed results were BMGS 12/18/18 11:42:00 AM
#494   I think I found where the IR lady bUrRpPPP! 12/18/18 07:53:55 AM
#493   Tradeable Float around 1M shares ONLY! if FairviewInvestor 12/18/18 06:54:05 AM
#492   Valuation now under $10M. End Game is near FairviewInvestor 12/18/18 06:53:10 AM
#491   Added .93 getting ridiculous FairviewInvestor 12/18/18 06:52:49 AM
#490   Added little under 1.08 FairviewInvestor 12/13/18 04:05:38 PM
#489   Hopefully that's the end of ACInvestor followers dumping. FairviewInvestor 12/13/18 02:22:23 PM
#488   Sherri M. Brown, Ph.D., Former Monsanto Executive, joins FairviewInvestor 12/13/18 09:06:54 AM
#487   Look for 3004 gene presence.. if so, any FairviewInvestor 12/12/18 06:09:14 PM
#486   Company said Data release in Q4 - not FairviewInvestor 12/12/18 06:07:18 PM
#485   Added another 5K from 1.22 down to 1.11 today FairviewInvestor 12/12/18 06:06:49 PM
#484   took a few on 1.40 brk yankees18 12/10/18 03:17:45 PM
#483   Increasing Crop Yield Through Smart Approaches In Trait Discovery BMGS 12/04/18 03:02:45 AM
#482   Article with direct YTEN mention CRISPR FairviewInvestor 12/03/18 12:52:22 PM
#481   To fulfill biofuels’ promise, scientists boost plant oils BMGS 11/28/18 09:11:25 AM
#480   The issue was mentioned in the recent conference call. BMGS 11/15/18 01:18:36 PM
#479   Maybe Monsanto is going to cross mj with nsomniyak 11/12/18 07:49:04 PM
#478   YTEN in bed with Monsanto.. what if? FairviewInvestor 11/12/18 02:04:25 PM
#477   MONSANTO getting into MJ FairviewInvestor 11/12/18 08:50:15 AM
#476   The Meteoric Rise of Genomics BMGS 11/08/18 12:58:57 PM
#475   Some great news would be nice for sure. BMGS 10/24/18 02:27:27 PM
#474   Range Bound until next News FairviewInvestor 10/17/18 06:02:32 AM
#473   2018 Field Tests for C3003 and C3008 Traits BMGS 10/03/18 03:35:27 PM
#472   Recent news releases underline the big potential of BMGS 10/03/18 02:09:39 PM
#471   Agree. A debt-free too. ash111 10/02/18 08:48:50 AM
#470   $14M Valuation crazy low considering progress. FairviewInvestor 10/02/18 08:36:54 AM
#469   CRISPR Non-Regulated Status approved FairviewInvestor 10/02/18 08:36:04 AM
#468   What’s up here? Eagle1 09/21/18 07:50:45 PM
#467   Today's news release is very promising imo. Land BMGS 09/21/18 01:43:55 PM
#466   Yield10 Bioscience Grants Research License to Forage Genetics BMGS 09/21/18 09:13:21 AM
#465   WOW- Here is how Crispr/Cas9 will change ash111 09/18/18 10:34:27 AM
#464   Would be Nice and looking forward to some news FairviewInvestor 09/16/18 08:54:47 PM
#463   . ash111 09/12/18 02:19:04 PM
#462   An interedting information by eximiuscapitalgroup StockTwits. I'm connecting ash111 09/11/18 04:26:16 PM
#461   Company just mentioned many opportunities : partnership... Page ash111 09/11/18 03:41:06 PM
#460   SSR SEC restriction on. = shorts were artificially FairviewInvestor 09/10/18 04:46:49 PM
#459   I hope everyone read through data that was FairviewInvestor 09/07/18 02:04:24 PM
#458   This is a High Risk / High Reward FairviewInvestor 09/07/18 01:30:31 PM
#457   picked up a bunch @ $1.42 today.. who FairviewInvestor 09/07/18 01:28:42 PM
PostSubject